Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: Benefits and limits of radioiodine therapy

Journal of Clinical Endocrinology and Metabolism

Volumn 91, Issue 8, 2006, Pages 2892-2899

  Durante, C ^a   Haddy, N ^b   Baudin, E ^a   Leboulleux, S ^a   Hartl, D ^a   Travagli, J P ^a   Caillou, B ^a   Ricard, M ^a   Lumbroso, J D ^a   De Vathaire, F ^b   Schlumberger, M ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; THYROGLOBULIN; THYROXINE;

ARTICLE; BONE METASTASIS; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DISEASE COURSE; DRUG ACTIVITY; FEMALE; HORMONAL THERAPY; HUMAN; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; THORAX RADIOGRAPHY; THYROGLOBULIN BLOOD LEVEL; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; TREATMENT OUTCOME; TUMOR RECURRENCE;

EID: 33747642244     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2005-2838     Document Type: Article

References (33)

1. Mazzaferri EL, Kloos RT 2001 Current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 86:1447-1463
2. Schlumberger MJ, Filetti S, Hay ID 2003 Non toxic goiter and thyroid neoplasia. In: Larsen RP, Kronenberg HM, Melmed S, Polonsky KS, eds. Williams' textbook of endocrinology. 10th ed. Philadelphia: WB Saunders Company; 457-490
3. Maxon HR, Smith HS 1990 Radioiodine-131 in the diagnosis and treatment of metastatic well differentiated thyroid cancer. Endocrinol Metab Clin N Am 19:685-718
4. 131I for the treatment of differentiated thyroid carcinoma. J Nucl Med 46:28S-37S
5. Bernier MO, Leenhardt L, Hoang C, Aurengo A, Mary JY, Menegaux F, Enkaoua E, Turpin G, Chiras J, Saillant G, Hejblum G 2001 Survival and therapeutic modalities in patients with bone metastases of differentiated thyroid carcinomas. J Clin Endocrinol Metab 86:1568-1573
6. Smit JWA, Vielvoye GJ, Goslings BM 2000 Embolization for vertebral metastases of follicular thyroid carcinoma. J Clin Endocrinol Metab 85:989-994
7. Tubiana M, Haddad E, Schlumberger M, Hill C, Rougier P, Sarrazin D 1985 External radiotherapy in thyroid cancers. Cancer 55:2062-2071
8. Schlumberger M, Challeton C, De Vathaire F, Travagli JP, Gardet P, Lumbroso JD, Francese C, Fontaine F, Ricard M, Parmentier C 1996 Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma. J Nucl Med 37:598-605
9. Casara D, Rubello D, Saladini G, Masarotto G, Favero A, Girelli ME, Busnardo B 1993 Different features of pulmonary metastases in differentiated thyroid cancer: natural history and multivariate statistical analysis of prognostic variables. J Nucl Med 34:1626-1631
10. Dinneen SF, Valimaki MJ, Bergstralh EJ, Goellner JR, Gorman CA, Hay ID 1995 Distant metastases in papillary thyroid carcinoma: 100 cases observed at one institution during 5 decades. J Clin Endocrinol Metab 80:2041-2045
11. Hindie E, Mellière D, Lange F, Hallaj I, de Labriolle-Vaylet C, Jeanguillaume C, Lange J, Perlemuter L, Askienazy S 2003 Functioning pulmonary metastases of thyroid cancer: does radioiodine influence the prognosis? Eur J Nucl Med Mol Imaging 30:974-981
12. Lin JD, Chao TC, Chou SC, Hsueh C 2004 Papillary thyroid carcinomas with lung metastases. Thyroid 14:1091-1096
13. Nemec J, Zamrazil V, Pohunkova D, Rohling A 1979 Radioiodine treatment of pulmonary metastases of differentiated thyroid cancer. Results and prognostic factors. Nuklearmedizin 18:86-90
14. Pacini F, Cetani F, Miccoli P, Mancusi F, Ceccarelli C, Lippi F, Martino E, Pinchera A 1994 Outcome of 309 patients with metastatic differentiated thyroid carcinoma treated with radioiodine. World J Surg 18:600-604
15. Pittas AG, Adler M, Fazzari M, Tickoo S, Rosai J, Larson SM, Robbins RJ 2000 Bone metastases from thyroid carcinoma: clinical characteristics and prognostic variables in one hundred forty-six patients. Thyroid 10:261-268
16. Rubino C, De Vathaire F, Dottorini ME, Hall P, Schvartz C, Couette JE, Dondon MG, Abbas MT, Langlois C, Schlumberger M 2003 Second primary malignancies in thyroid cancer patients. Br J Cancer 89:1638-1644
17. Kloos RT, Duvuuri V, Jhiang SM, Cahill KV, Foster JA, Burns JA 2002 Nasolacrimal drainage system obstruction from radioactive iodine therapy for thyroid carcinoma. J Clin Endocrinol Metab 87:5817-5820
18. Mandel SJ, Mandel L 2003 Radioactive iodine and the salivary glands. Thyroid 13:265-271
19. Shimaoka K, Schoenfeld DA, De Wys WD, Creech RH, De Conti RA 1985 Randomized trial of Doxorubicin versus Doxorubicin plus Cisplatin in patients with advanced thyroid carcinoma. Cancer 56:2155-2160
20. Williams SD, Birch R, Einhorn LH 1986 Phase II evaluation of Doxorubicin plus Cisplatin in advanced thyroid cancer: a Southeastern Cancer Study Group Trial. Cancer Treat Rep 70:405-407
21. Braga-Brasaria M, Ringel MD 2003 Beyond radioiodine: a review of potential new therapeutic approaches for thyroid cancer. J Clin Endocrinol Metab 88:1947-1960
22. Reiners C 2003 Radioiodine therapy in patients with pulmonary metastases of thyroid cancer: when to treat, when not to treat? Eur J Nucl Med Mol Imaging 30:939-942
23. 18F] fluoro-2-deoxy-D-glucose positron emission tomography. J Clin Endocrinol Metab 91:498-505
24. Hedinger C, Williams ED, Sobin LH 1988 Histological typing of thyroid tumours. In: International histological classification of tumours. World Health Organization. Vol 11. 2nd ed. Berlin: Springer-Verlag
25. Rosai J 1996 Ackerman's surgical pathology. 8th ed. St. Louis, MO: Mosby; 1318
26. Biondi B, Filetti S, Schlumberger M 2005 Thyroid-hormone therapy and thyroid cancer: a reassessment. Nat Clin Pract Endocrinol Metab 1:32-40
27. Demers LM, Spencer CA 2003 Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 13:4-126
28. 131I therapy for elevated thyroglobulin levels. Thyroid 7:273-276
29. Park HM, Perkins OW, Edmondson JW, Schnute RB, Manatunga A 1994 Influence of diagnostic radioiodines on the uptake of ablative dose of iodine-131. Thyroid 4:49-54
30. Droz JP, Schlumberger M, Rougier P, Ghosn M, Gardet P, Parmentier C 1990 Chemotherapy in metastatic nonanaplastic thyroid cancer: experience at the Institut Gustave-Roussy. Tumori 76:480-483
31. 131I) treatment of hyperthyroidism. In: Freeman LM, Miller JM, eds. Nuclear medicine annual. New York: Raven Press; 265-290
32. Baudin E, Do Cao C, Cailleux AF, Leboulleux S, Travagli JP, Schlumberger M 2003 Positive predictive value of serum thyroglobulin levels, measured during the first year of follow up after thyroid hormone withdrawal, in thyroid cancer patients. J Clin Endocrinol Metab 88:1107-1111
33. 131I activities versus untreated patients. J Clin Endocrinol Metab 86:4092-4097